BioTelemetry, Inc. Announces Its Latest Success In Patent Enforcement
The Eastern District Court of Pennsylvania Has Found MedTel24, Inc. in Contempt
Malvern, Pa., Oct. 06, 2015 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce that the Honorable Juan R. Sanchez of the Eastern District of Pennsylvania has issued an October 2, 2015 Order finding MedTel24, Inc. (“MedTel”) in contempt of a Consent Judgment previously issued by the Court. The previously issued Consent Judgment declared all five asserted BioTelemetry patents valid, enforceable and infringed by MedTel. The Consent Judgment also declared that MedTel is permanently enjoined from further infringement and is required to deliver to BioTelemetry all software, source code, hardware, and documentation relating to the Heartrak ECAT system.
In the recent Order, Judge Sanchez specifically found that BioTelemetry, “has established by clear and convincing evidence that MedTel is in contempt of the Consent Judgment.” MedTel was ordered to return, within 21 days of the Order, all of the Heartrak ECAT materials it improperly retained in violation of the Consent Judgment. Judge Sanchez has further ordered that MedTel’s CEO is required to submit a declaration to the Court that all of the materials have been returned within the 21-day window. To ensure MedTel’s compliance, the Order also provided for a substantial fine of $20,000 per day for each day beyond the 21 days that MedTel fails to deliver the materials as directed.
The Court will issue a separate Order addressing MedTel’s other potential violations of the Consent Judgment and BioTelemetry’s requests for lost profits, expenses, attorneys’ fees and sanctions.
BioTelemetry is represented by a litigation team from Ropes & Gray LLP’s Manhattan office.
About BioTelemetry
BioTelemetry, Inc., formerly known as CardioNet, Inc., is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The Company currently provides cardiac monitoring services, original equipment manufacturing with a primary focus on cardiac monitoring devices and centralized cardiac core laboratory services. More information can be found at www.gobio.com.
Help employers find you! Check out all the jobs and post your resume.
Malvern, Pa., Oct. 06, 2015 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce that the Honorable Juan R. Sanchez of the Eastern District of Pennsylvania has issued an October 2, 2015 Order finding MedTel24, Inc. (“MedTel”) in contempt of a Consent Judgment previously issued by the Court. The previously issued Consent Judgment declared all five asserted BioTelemetry patents valid, enforceable and infringed by MedTel. The Consent Judgment also declared that MedTel is permanently enjoined from further infringement and is required to deliver to BioTelemetry all software, source code, hardware, and documentation relating to the Heartrak ECAT system.
In the recent Order, Judge Sanchez specifically found that BioTelemetry, “has established by clear and convincing evidence that MedTel is in contempt of the Consent Judgment.” MedTel was ordered to return, within 21 days of the Order, all of the Heartrak ECAT materials it improperly retained in violation of the Consent Judgment. Judge Sanchez has further ordered that MedTel’s CEO is required to submit a declaration to the Court that all of the materials have been returned within the 21-day window. To ensure MedTel’s compliance, the Order also provided for a substantial fine of $20,000 per day for each day beyond the 21 days that MedTel fails to deliver the materials as directed.
The Court will issue a separate Order addressing MedTel’s other potential violations of the Consent Judgment and BioTelemetry’s requests for lost profits, expenses, attorneys’ fees and sanctions.
BioTelemetry is represented by a litigation team from Ropes & Gray LLP’s Manhattan office.
About BioTelemetry
BioTelemetry, Inc., formerly known as CardioNet, Inc., is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The Company currently provides cardiac monitoring services, original equipment manufacturing with a primary focus on cardiac monitoring devices and centralized cardiac core laboratory services. More information can be found at www.gobio.com.
Help employers find you! Check out all the jobs and post your resume.